论文信息 - Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia - 字舞流文

Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia

Peter A. Jones | Philip J. Chapman | P. Grandi | S. Baylin | J. Luengo | M. Bantscheff | J. Briand | R. Prinjha | Mark Cockerill | A. P. Graves | Xiaodong Cheng | D. Mcnulty | Xing Zhang | H. Eberl | A. Gilmartin | Thilo Werner | Wendy A. Kellner | M. Pappalardi | M. T. McCabe | R. Kruger | A. Rutkowska | N. Campobasso | S. P. Romeril | D. Heerding | E. Minthorn | B. W. King | A. Jordan | D. Ogilvie | H. Mohammad | I. Waddell | Sarath Pathuri | Charles F. McHugh | Michael Steidel | T. Ho | Susan L Merrihew | Andrew B. Benowitz | Mehul P. Patel | Shawn W Foley | Jon-Paul Jaworski | Arthur Groy | Emma E. Fairweather | A. Stowell | Lourdes Rueda | M. Muliaditan | K. Goldberg | A. Jurewicz | R. Butlin | C. Carpenter | C. Sherk | Ashley K. Wiseman | A. Raoof | Kristen Wong | Cunyu Zhang | Jessica L. Handler | Makda Mebrahtu | Amy N. Taylor | Kathryn Keenan | J. Horton | David T. Fosbenner | Charlotte L. Burt | Mei Li | Christopher S. Kershaw | S. Pathuri